about
The role of AGR2 and AGR3 in cancer: similar but not identical.AGR2 associates with HER2 expression predicting poor outcome in subset of estrogen receptor negative breast cancer patients.AGR2 oncoprotein inhibits p38 MAPK and p53 activation through a DUSP10-mediated regulatory pathway.Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition.Targeted proteomics driven verification of biomarker candidates associated with breast cancer aggressiveness.
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Roman Hrstka
@en
Roman Hrstka
@nl
type
label
Roman Hrstka
@en
Roman Hrstka
@nl
prefLabel
Roman Hrstka
@en
Roman Hrstka
@nl
P31
P496
0000-0002-6139-2664